Ahead of his participation in Pharma Contract Manufacturing 2018, Pharma IQ spoke exclusively with Luiz Barberini to discuss managing relationships with contract manufacturers. From this discussion we have put together this handy pocket guide which covers topics including conflict management, mitigating risks and building resourceful and lasting relationship with contractors.
Nowadays, nearly 80% of drugs currently FDA approved on behalf of small bio/pharma companies are contract manufactured, and 50% of products supported by mid-size companies use a CMO. In the lead up to the Pharma Contract Manufacturing Conference, Pharma IQ have looked at the evolution of the roles of CMOs and CDMOs in the industry, and what the future will bring for these organisations.
When building a resourceful and reliable relationship with a CMO it is critical that both companies understand each other’s culture, mission and values. Pharma IQ caught up with Christophe Stevens, Associate Director External Manufacturing, UCB and Christophe Defrance, External Manufacturing Director, UCB to discuss the optimisation and consolidation of their extensive CMO network.